Seeing hope: FDA panel considers gene therapy for blindness
Advisers to the U.S. Food and Drug Administration will meet Thursday to consider whether to recommend approval of a gene therapy aimed at restoring vision for some people with hereditary blindness (Oct. 10)
0 Comments